Exchange: NYSE·Updated 04:59 PM EDT
News
all
press releases
"Fibermaxxing" Craze Forces Big Food into Reformulation Cycle
"Fibermaxxing" Craze Forces Big Food into Reformulation Cycle BNP Paribas analysts say Gen Z's growing awareness of healthy, high-protein, high-fiber diets is accelerating a reformulation cycle across the Big Food industrial complex, as manufacturers race to make products more...
Zero Hedge
More News
3 AgTech & Food Innovation Stocks to Buy as the Industry Evolves
AgTech and food innovation reshape agriculture and nutrition, putting ADM, DAR and BG firmly in focus.
Zacks
Archer Daniels Earnings Boost Biofuels and Crush Capacity Growth Prospects Now
ADM is benefiting from stronger biofuels economics and crushing margins while capacity investments support additional growth.
Zacks
ADM Stock: Growth Gains vs. Valuation and Execution Risks Remain Ahead
Archer Daniels raises its 2026 earnings outlook after a strong Q2, as crushing, ethanol and Nutrition gains fuel profit growth while execution risks remain.
Zacks
Ingredion Q2 Earnings Beat Estimates on T&HS Volume Growth
Ingredion beats Q2 estimates as 7% Texture & Healthful Solutions volume growth and FX gains offset Argo issues and higher costs.
Zacks
Ingredion (INGR) Q2 Earnings and Revenues Beat Estimates
Ingredion (INGR) delivered earnings and revenue surprises of +3.30% and +2.32%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
How Ingredion's Tate & Lyle Deal Could Reshape Its Growth Outlook
Ingredion's proposed $5 billion Tate & Lyle deal could expand its specialty platform and global reach, but approvals and integration risks remain.
Zacks
Is Ingredion Stock a Buy as Cheap Valuation Meets Execution Risk?
Ingredion's cheap valuation and growing specialty business support the bull case, but Argo execution risks and weaker guidance argue for patience.
Zacks
Kraft Heinz (KHC) Expected to Beat Earnings Estimates: Should You Buy?
Kraft Heinz (KHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
Analysts Estimate Ingredion (INGR) to Report a Decline in Earnings: What to Look Out for
Ingredion (INGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks

Advertisement|Remove ads.